Glass House Brands (GLAS) Depreciation & Amortization (CF) (2020 - 2026)

Glass House Brands' (GLAS) quarterly Depreciation & Amortization (CF) came in at $4.0 million in Q1 2026, up 4.82% year-on-year from $3.8 million in Q1 2025, and up 23.22% on a QoQ basis from $3.3 million in Q4 2025.

Glass House Brands (GLAS) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $4.0 million in Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 4.82% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $15.2 million, a 0.13% change from a year earlier, with the FY2025 full-year figure at $15.0 million, changed 0.29% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $4.0 million, up from $3.3 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for GLAS reached as high as $4.0 million in Q1 2026 and fell as low as $2.6 million in Q1 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $3.6 million across 5 years, with a median of $3.7 million in 2024.
  • Across the five-year window, Depreciation & Amortization (CF) soared 339.13% in 2022 and dropped 15.75% in 2025, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $3.4 million in 2022, then grew by 3.88% to $3.5 million in 2023, then grew by 9.27% to $3.9 million in 2024, then decreased by 15.75% to $3.3 million in 2025, then rose by 23.22% to $4.0 million in 2026.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $4.0 million in Q1 2026, $3.3 million in Q4 2025, and $4.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 239.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 22.60 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 172.00 Mn
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn 4.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.02 Mn
Mar 31, 2026 4.02 Mn
Dec 31, 2025 3.26 Mn
Dec 31, 2025 3.26 Mn
Sep 30, 2025 3.99 Mn
Sep 30, 2025 3.99 Mn
Jun 30, 2025 3.91 Mn
Jun 30, 2025 3.91 Mn
Mar 31, 2025 3.84 Mn
Mar 31, 2025 3.84 Mn
Dec 31, 2024 3.87 Mn
Dec 31, 2024 3.87 Mn
Sep 30, 2024 3.73 Mn
Sep 30, 2024 3.73 Mn
Jun 30, 2024 3.72 Mn
Jun 30, 2024 3.72 Mn
Mar 31, 2024 3.72 Mn
Mar 31, 2024 3.72 Mn
Dec 31, 2023 3.55 Mn
Dec 31, 2023 3.55 Mn